Komu, kiedy i w jakiej dawce? Miejsce arypiprazolu w leczeniu schizofrenii i choroby afektywnej dwubiegunowej

Anna Z. Antosik-Wójcińska

Open source

DOI: 10.15557/pipk.2018.0022
Published: 6
Container: Psychiatria i Psychologia Kliniczna
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15557/pipk.2018.0022,
  title = {Komu, kiedy i w jakiej dawce? Miejsce arypiprazolu w leczeniu schizofrenii i choroby afektywnej dwubiegunowej},
  author = {Anna Z. Antosik-Wójcińska},
  year = {2018},
  journal = {Psychiatria i Psychologia Kliniczna},
  doi = {10.15557/pipk.2018.0022},
  url = {https://doi.org/10.15557/pipk.2018.0022}
}

RIS

TY  - JOUR
TI  - Komu, kiedy i w jakiej dawce? Miejsce arypiprazolu w leczeniu schizofrenii i choroby afektywnej dwubiegunowej
AU  - Anna Z. Antosik-Wójcińska
PY  - 2018
JO  - Psychiatria i Psychologia Kliniczna
DO  - 10.15557/pipk.2018.0022
UR  - https://doi.org/10.15557/pipk.2018.0022
ER  -

APA

Antosik-Wójcińska, A. Z. (2018). Komu, kiedy i w jakiej dawce? Miejsce arypiprazolu w leczeniu schizofrenii i choroby afektywnej dwubiegunowej. Psychiatria i Psychologia Kliniczna. https://doi.org/10.15557/pipk.2018.0022

Source records

doaj · retrieved 2026-09-25T11:06:01.340Z